Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Lazzarin

Showing results (91-100 of 288) with videos related to

Pageof 29
Sort By:
International Journal of Antimicrobial Agents|July 17, 2018
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimenNicola Gianotti, Laura Galli, Nadia Galizzi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2009
Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failureFrancesca Cossarini, Laura Galli, Caterina Sagnelli, et al.
Memorias Do Instituto Oswaldo Cruz|June 8, 2017
The use of circulating cathodic antigen rapid test and serology for diagnosis of active Schistosoma mansoni infection in migrants in Italy, a non-endemic country: a cross sectional studyLaura Infurnari, Laura Galli, Alba Bigoloni, et al.
AIDS (London, England)|April 12, 2005
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failuresMargaret Johnson, Beatriz Grinsztejn, Claudia Rodriguez, et al.
Medicine|June 4, 2016
Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or AbacavirNicola Gianotti, Laura Galli, Andrea Poli, et al.
The New Microbiologica|April 21, 2020
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infectionFrancesca Rinaldi, Serena Rolla, Laura Galli, et al.
The New Microbiologica|October 21, 2015
Early diagnosis and retention in care of HIV-infected patients through rapid salivary testing: a test-and-treat fast track pilot studyMaria Rita Parisi, Laura Soldini, Silvia Negri, et al.
The New Microbiologica|March 1, 2016
Early diagnosis and retention in care of HIV-infected patients through rapid salivary testing: a test-and-treat fast track pilot studyMaria Rita Parisi, Laura Soldini, Silvia Negri, et al.
HIV Clinical Trials|July 13, 2004
Nitric oxide production in HIV-1 infected patients receiving intermittent cycles of interleukin-2 and antiretroviralsDonato Torre, Filippo Speranza, Silvia Ghezzi, et al.
The New Microbiologica|March 3, 2018
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trialElisa Colella, Dario Cattaneo, Laura Galli, et al.
Pageof 29

Showing results (91-100 of 288) with videos related to

Sort By:
Pageof 29
International Journal of Antimicrobial Agents|July 17, 2018
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimenNicola Gianotti, Laura Galli, Nadia Galizzi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2009
Survival of HIV-1 infected multidrug-resistant patients recycling enfuvirtide after a previous failureFrancesca Cossarini, Laura Galli, Caterina Sagnelli, et al.
Memorias Do Instituto Oswaldo Cruz|June 8, 2017
The use of circulating cathodic antigen rapid test and serology for diagnosis of active Schistosoma mansoni infection in migrants in Italy, a non-endemic country: a cross sectional studyLaura Infurnari, Laura Galli, Alba Bigoloni, et al.
AIDS (London, England)|April 12, 2005
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failuresMargaret Johnson, Beatriz Grinsztejn, Claudia Rodriguez, et al.
Medicine|June 4, 2016
Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or AbacavirNicola Gianotti, Laura Galli, Andrea Poli, et al.
The New Microbiologica|April 21, 2020
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infectionFrancesca Rinaldi, Serena Rolla, Laura Galli, et al.
The New Microbiologica|October 21, 2015
Early diagnosis and retention in care of HIV-infected patients through rapid salivary testing: a test-and-treat fast track pilot studyMaria Rita Parisi, Laura Soldini, Silvia Negri, et al.
The New Microbiologica|March 1, 2016
Early diagnosis and retention in care of HIV-infected patients through rapid salivary testing: a test-and-treat fast track pilot studyMaria Rita Parisi, Laura Soldini, Silvia Negri, et al.
HIV Clinical Trials|July 13, 2004
Nitric oxide production in HIV-1 infected patients receiving intermittent cycles of interleukin-2 and antiretroviralsDonato Torre, Filippo Speranza, Silvia Ghezzi, et al.
The New Microbiologica|March 3, 2018
Potential associations between atazanavir exposure and clinical outcome: a pharmacokinetic sub-study from the MODAt randomized trialElisa Colella, Dario Cattaneo, Laura Galli, et al.
Pageof 29